Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location:Home > Pharma China Web Edition > Editor´s Picks    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Editor´s Picks
 
Investing in China's Healthtech Industry
 
7-26-2019

China’s healthcare industry is facing an onset of new challenges due to its rapidly ageing population. There is now an ostensible gap between the medical resources available and the current health needs of the nation.

Still, China is uniquely placed. A combination of factors – its large middle class, advanced technology capabilities, and strong government support – creates key capacity to produce innovative solutions for the market.

China’s healthcare system has also made significant strides. Within the last two decades the country has benefited from large-scale reforms of its medical infrastructure, insurance system, as well as the opening-up of its healthcare market.

This China Briefing article by Dorcas Wong reports that "as the challenges to China’s healthcare industry grow and diversify, so do the opportunities – its healthcare market is expected to reach CNY 198 billion (US$28.For full text of this Bloomberg News article, please visit the following weblink:

https://www.china-briefing.com/news/investing-chinas-healthtech-industry/

This is not an article published by Pharma China, and please visit the above website links for the full text of the article. The availability of the article is under the control of its publisher. We may occationally keep a copy of the article offline, so subscribers who cannot access the article online can contact info@pharmachinaonline.com for further information.59 billion) in 2026,  increasing tenfold from 2016".

 
 
Relate Articles  
 
 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links